Skip to content

Intrathecal Bupivacaine-fentanyl and Bupivacaine-dexmedetomidine for Elective Low Segment Caesarean Section

Comparative Evaluation of Intrathecal Bupivacaine-fentanyl and Bupivacaine-dexmedetomidine for Elective Low Segment Caesarean Section

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04095013
Enrollment
60
Registered
2019-09-19
Start date
2019-02-01
Completion date
2019-07-15
Last updated
2019-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section Complications

Keywords

Elective low segment caesarean section, Intrathecal, bupivacaine-fentanyl, bupivacaine-dexmedetomidine, sensory block, complications, hemodynamics

Brief summary

the primary objective of the study is to compare the onset and recovery times of sensory and motor blockade of the two study drugs intrathecally with low dose bupivacaine The secondary objectives of the study are to observe hemodynamics, side effects profile, and duration of postoperative analgesia

Detailed description

The current study is undertaken to compare the effect of two drugs intrathecally.edexmedetomidine and fentanyl with a low dose of bupivacaine and assess the adequacy of the block, side effect profile and postoperative analgesia. The two drugs have been studied separately but the comparative data is scarcely available both at national and international level. A particular agent is a dexmedetomidine that has been introduced in the investiagator's setup for the first time so this research will be of great importance in adding its multiple uses other than being used as ICU and procedural sedation agent.

Interventions

Group A: hyperbaric Bupivacaine 10mg with fentanyl 10micrograms,

DRUGBupivacaine, dexmedetomidine

Group B: hyperbaric Bupivacaine 10 mg with dexmedetomidine5 micrograms

Sponsors

Dow University of Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Caregiver)

Masking description

Patients were randomly allocated into two groups and will be blinded to the study drugs. The drugs will be chosen by seal envelope method by principal investigator and co-investigator. The drugs will be filled in the syringes and the syringes handed over to on floor consultant anesthetist who are blinded to the study.

Intervention model description

Randomize controlled trial (RCT)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

Term pregnancy Singleton ASA I and II, BMI \<35, elective C/section

Exclusion criteria

patient refusal, contraindications to spinal anaesthesia. ASA III and IV, PIH Pre Eclampsia, allergic to Local Anesthetic, fetal anomalies.

Design outcomes

Primary

MeasureTime frameDescription
Time till T10 dermatome achieved (Sec)Post operative initial hourSpinal block characteristics
Post-operative pain score1 hourVAS score indicate 0 no pain 10 severe pain. Pain score was noted down
Time of complete motor recovery (Min)Post operative initial hourSpinal block characteristics
Regression time to T10 dermatome (Min)Post operative initial hourSpinal block characteristics
Time of maximum bromage achieved (Sec)Post operative initial hourSpinal block characteristics

Secondary

MeasureTime frameDescription
Respiratory distress24 hours Post operativeDifficulty in breathing
Nausea24 hours Post operativeSensation to throw out stomach contents
Vomiting24 hours Post operativeAct of throwing out stomach contents through mouth
Pruritus24 hours Post operativeUnpleasing sensation on the skin that provokes to scratch
Shivering24 hours Post operativeThe act of shaking slightly and uncomfortably due to felling of cold temperature
Bradycardia24 hours Post operativeHeat rate less than \<60 bpm
Hypotension24 hours Post operativeDecrease in BP greater than 20% of baseline

Other

MeasureTime frameDescription
SBPat 10 minuteHemodynamics
respiratory rateBaselineHemodynamics
oxygen saturationBaselineHemodynamics
Systolic Blood PressureBaselineHemodynamics
Heart RateBaselineHemodynamics
Diastolic Blood PressureBaselineHemodynamics

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026